The Rundown cover image

Why Venezuela Didn’t Break the Oil Market, Novo Launches Wegovy Pill

The Rundown

00:00

WeGovie pill limitations

Zaid notes Novo Nordisk's 30-minute post-dose restriction compared with Eli Lilly's pill lacking that limitation.

Play episode from 05:51
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app